YESHA THAKKAR: Open Payments
NPI 1275066565 · VILLA RICA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 31 payments from 9 companies in 2025. Trend: 2023 $543 · 2024 $553 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Alkermes, Inc. | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Corium, LLC | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Tris Pharma Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, Qelbree, Azstarys, INGREZZA, ABILIFY ASIMTUFII, Dyanavel XR.
Industry payments across GA — which companies pay providers there.
